PRALIDOXIME CHLORIDE (AUTOINJECTOR) Drug Patent Profile
✉ Email this page to a colleague
When do Pralidoxime Chloride (autoinjector) patents expire, and when can generic versions of Pralidoxime Chloride (autoinjector) launch?
Pralidoxime Chloride (autoinjector) is a drug marketed by Meridian Medcl Techn and is included in one NDA.
The generic ingredient in PRALIDOXIME CHLORIDE (AUTOINJECTOR) is pralidoxime chloride. There are five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the pralidoxime chloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PRALIDOXIME CHLORIDE (AUTOINJECTOR)?
- What are the global sales for PRALIDOXIME CHLORIDE (AUTOINJECTOR)?
- What is Average Wholesale Price for PRALIDOXIME CHLORIDE (AUTOINJECTOR)?
Summary for PRALIDOXIME CHLORIDE (AUTOINJECTOR)
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | PRALIDOXIME CHLORIDE (AUTOINJECTOR) at DailyMed |
-patent-expirations.png "PRALIDOXIME CHLORIDE (AUTOINJECTOR) drug patent expirations")
US Patents and Regulatory Information for PRALIDOXIME CHLORIDE (AUTOINJECTOR)
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Meridian Medcl Techn | PRALIDOXIME CHLORIDE (AUTOINJECTOR) | pralidoxime chloride | SOLUTION;INTRAMUSCULAR | 018986-001 | Apr 26, 1983 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
